Ketoplus (Ketoprofen)

Ketoprofen works by blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, the drug diminishes the inflammatory response, reduces pain signalling, and helps lower fever, providing symptomatic relief in affected tissues.

The appropriate dose of Ketoplus is determined by the prescribing healthcare professional based on the individual’s medical condition, age, weight, and response to therapy. Patients should follow the prescriber’s instructions and never adjust the dose without medical guidance.

Safety of ketoprofen in pregnancy and lactation has not been definitively established. It is generally avoided, especially in the third trimester, because of potential risks to the fetus and newborn. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative treatments with their healthcare provider.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoplus (ketoprofen) offers analgesic and anti‑inflammatory potency comparable to ibuprofen and naproxen, but it may have a slightly higher risk of gastrointestinal irritation. Its relatively short half‑life allows flexible dosing, while some clinicians prefer it for conditions where a rapid onset of pain relief is desired.

Ketoplus should be stored at room temperature, preferably below 25 °C. Keep the tablets in the original packaging to protect them from moisture and light, and store them out of reach of children.

Ketoplus is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with meals may reduce the likelihood of stomach upset. The exact administration schedule should follow the prescriber’s directions.

The most serious risks include gastrointestinal bleeding or ulceration, severe renal impairment, life‑threatening allergic reactions such as Stevens‑Johnson syndrome, and increased cardiovascular events like heart attack or stroke. Patients should seek immediate medical attention if they notice signs of bleeding, severe rash, or sudden kidney problems.

Ketoplus should be avoided in individuals with known hypersensitivity to ketoprofen or other NSAIDs, active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. It is also contraindicated in patients taking certain anticoagulants or other NSAIDs without medical supervision.